Theravance Biopharma, Inc. (TBPH) Other
Market cap
$849.63M
P/E ratio
8x
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | -14.1 | -14.3 | -16.1 | -10 | -13.5 | -13.3 | -7.6 | 177.6 | -1.7 | -4.2 | 25.2 |
| Return on equity (%) | - | - | - |